Showing results (721-730 of 2,547) with videos related to
Sort By:
Pageof 255
American Journal of Therapeutics|May 11, 2004
Regulatory toxicology perspectives on the development of botanical drug products in the United StatesKuei-Meng Wu, James Farrelly, Debra Birnkrant, et al.American Journal of Therapeutics|March 5, 2004
Pharmacoscintigraphic comparison of HMR 1031, a VLA-4 antagonist, in healthy volunteers following delivery via a nebulizer and a dry powder inhalerShashank Rohatagi, Sunny Chapel, Stephane Kirkesseli, et al.American Journal of Therapeutics|March 5, 2004
A Mathematical simulation to explain the coordinated functions of efflux and metabolism limiting the transport of anti-HIV agents across Caco-2 cellsJignesh Patel, Azher Hussain, Dhahanjay Pal, et al.American Journal of Therapeutics|January 6, 2004
Economic analysis of sildenafil citrate (Viagra) add-on to treat erectile dysfunction associated with selective serotonin reuptake inhibitor useH George Nurnberg, Sandeep DuttaguptaAmerican Journal of Therapeutics|January 6, 2004
Patient characteristics and risks factors for development of dependence on hydrocodone and oxycodoneNorman S Miller, Andrea GreenfeldAmerican Journal of Therapeutics|November 16, 2004
Examination of the cutaneous absorption of copper after the use of copper-containing ointmentsRobert W Gorter, Mario Butorac, Eloy Pulido CobianAmerican Journal of Therapeutics|November 16, 2004
Inhibition of human plasma leucine5-enkephalin aminopeptidase hydrolysis by various endogenous peptides and a select number of clinically used drugsAron D Mosnaim, Javier Puente, Vasant Ranade, et al.American Journal of Therapeutics|November 16, 2004
Evidence-based medical perspectives: the evolving role of PSA for early detection, monitoring of treatment response, and as a surrogate end point of efficacy for interventions in men with different clinical risk states for the prevention and progression of prostate cancerRonald LiebermanAmerican Journal of Therapeutics|March 16, 2005
Safety, tolerability, and effectiveness of oxymorphone extended release for moderate to severe osteoarthritis pain: a one-year studyHarris McIlwain, Harry AhdiehAmerican Journal of Therapeutics|March 16, 2005
Developmental phases of inflammation-induced massive lymphoid hyperplasia and extensive changes in epithelium in an experimental model of allergy: implications for a direct link between inflammation and carcinogenesisMahin KhatamiPageof 255